Viewing StudyNCT00042354



Ignite Creation Date: 2024-05-05 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00042354
Status: COMPLETED
Last Update Posted: 2015-03-05
First Post: 2002-07-26

Brief Title: Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia AML Patients
Sponsor: Genzyme a Sanofi Company
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Leukemia Myelocytic Acute Pediatric
Keywords:
Name View
Pediatric Acute Myelogenous Leukemia View
CLO222 View
clolar View